Skip to main content

Secondary menu

  • University of California San Francisco
  • About UCSF
  • Search UCSF
  • UCSF Medical Center

Synapse

The School Newspaper
  • Facebook profile for Synapse
  • Twitter profile for Synapse

Main menu

  • Arts
  • Career
  • Health
  • News
  • Opinion
  • Science
  • ColumnsToggle submenu for Columns
    • Between Degrees
    • Crossing Bridges
    • Diversity Spotlight
    • Ethical Brain Teasers
    • Humans of UCSF
    • NeuWrite
    • Rant Along With Ray
    • Research Spotlight
    • The Science Wonk
  • Submit An Article

Anna Lipkin

Contributor
Graduate Division
Student
  • Science
Monday, April 24, 2017 - 13:56

Baby Blues: Setbacks in Developing the Male Contraceptive

By Anna Lipkin
Amused, I clicked the hashtag #menaresofragile and learned that a clinical trial for TU NET-EN, an injectable male contraceptive, had been cancelled due to “intolerable side effects.” As I looked around the Internet that day, I saw that the hashtag reflected widespread outrage among women: we have had to stomach the unpleasant side effects of hormonal contraceptives for decades, and now an entire study is down the tubes because men can’t handle a little bit of acne?
Continue reading
UCSF Student Voices

Synapse is the UCSF student newspaper. We seek to serve as a forum for the campus community. Articles and columns represent the views of the authors and not necessarily those of the Board of Publications or the University of California.

  • Facebook profile for Synapse
  • Twitter profile for Synapse
  • RSS file for Synapse

Main menu:

  • Arts
  • Career
  • Health
  • News
  • Opinion
  • Science
  • Columns
  • Submit An Article

About:

  • Join our team
  • Meet our team
  • Board of Publications
  • Submit an ad
  • (415) 502-1484
  • [email protected]

Newsletter:

 

More than 50 years of Synapse are available at the Library's Synapse Archive